
Sign up to save your podcasts
Or


Join us to hear about the latest advancements in immunotherapy for advanced, intermediate-, and early-stage hepatocellular carcinoma (HCC).
Credit available for this activity expires: 11/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001794?ecd=bdc_podcast_libsyn_mscpedu
By Medscape Podcasts4
77 ratings
Join us to hear about the latest advancements in immunotherapy for advanced, intermediate-, and early-stage hepatocellular carcinoma (HCC).
Credit available for this activity expires: 11/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001794?ecd=bdc_podcast_libsyn_mscpedu

1,259 Listeners

320 Listeners

500 Listeners

304 Listeners

1,391 Listeners

180 Listeners

899 Listeners

14 Listeners

16 Listeners

298 Listeners

3,376 Listeners

8,740 Listeners

196 Listeners

516 Listeners

369 Listeners

62 Listeners

26 Listeners

426 Listeners